Effects of HNE-modification induced by Aβ on neprilysin expression and activity in SH-SY5Y cells

Rui Wang, Suqing Wang, James S. Malter, Deng Shun Wang

Research output: Contribution to journalArticle

32 Citations (Scopus)

Abstract

The cerebral accumulation of β-amyloid (Aβ) is a consistent feature of and likely contributor to the development of Alzheimer's disease. In addition to dysregulated production, increasing experimental evidence suggests reduced catabolism also plays an important role in Aβ accumulation. We have previously shown that neprilysin (NEP), the major protease which cleaves Aβin vivo, is modified by 4-hydroxy-nonenal (HNE) adducts in the brain of Alzheimer's disease patients. To determine if these changes affected Aβ, SH-SY5Y cells were treated with HNE or Aβ, and then NEP mRNA, protein levels, HNE adducted NEP, NEP activity and secreted Aβ levels were determined. Intracellular NEP developed HNE adducts after 24 h of HNE treatment as determined by immunoprecipitation, immunoblotting, and double immunofluorescence staining. HNE-modified NEP showed decreased catalytic activity, which was associated with elevations in Aβ1-40 in SH-SY5Y and H4 APP695wt cells. Incubation of cells with Aβ1-42 also induced HNE adduction of NEP. In an apparent compensatory response, Aβ-treated cells showed increased NEP mRNA and protein expression. Despite elevations in NEP protein, the activity was significantly lower compared with the NEP protein level. This study demonstrates that NEP can be inactivated by HNE-adduction, which is associated with, at least partly, reduced Aβ cleavage and enhanced Aβ accumulation.

Original languageEnglish (US)
Pages (from-to)1072-1082
Number of pages11
JournalJournal of Neurochemistry
Volume108
Issue number4
DOIs
StatePublished - Feb 2009

Fingerprint

Neprilysin
Alzheimer Disease
Proteins
Cells
Messenger RNA
Brain Diseases
Immunoprecipitation
Immunoblotting
Amyloid
Fluorescent Antibody Technique
Catalyst activity
Brain
Peptide Hydrolases

Keywords

  • β-amyloid
  • 4-hydroxy-nonenal
  • Alzheimer's disease
  • Degradation
  • Neprilysin
  • Oxidative stress

ASJC Scopus subject areas

  • Biochemistry
  • Cellular and Molecular Neuroscience

Cite this

Effects of HNE-modification induced by Aβ on neprilysin expression and activity in SH-SY5Y cells. / Wang, Rui; Wang, Suqing; Malter, James S.; Wang, Deng Shun.

In: Journal of Neurochemistry, Vol. 108, No. 4, 02.2009, p. 1072-1082.

Research output: Contribution to journalArticle

@article{6836f125bd094aa99a9a090f702045ff,
title = "Effects of HNE-modification induced by Aβ on neprilysin expression and activity in SH-SY5Y cells",
abstract = "The cerebral accumulation of β-amyloid (Aβ) is a consistent feature of and likely contributor to the development of Alzheimer's disease. In addition to dysregulated production, increasing experimental evidence suggests reduced catabolism also plays an important role in Aβ accumulation. We have previously shown that neprilysin (NEP), the major protease which cleaves Aβin vivo, is modified by 4-hydroxy-nonenal (HNE) adducts in the brain of Alzheimer's disease patients. To determine if these changes affected Aβ, SH-SY5Y cells were treated with HNE or Aβ, and then NEP mRNA, protein levels, HNE adducted NEP, NEP activity and secreted Aβ levels were determined. Intracellular NEP developed HNE adducts after 24 h of HNE treatment as determined by immunoprecipitation, immunoblotting, and double immunofluorescence staining. HNE-modified NEP showed decreased catalytic activity, which was associated with elevations in Aβ1-40 in SH-SY5Y and H4 APP695wt cells. Incubation of cells with Aβ1-42 also induced HNE adduction of NEP. In an apparent compensatory response, Aβ-treated cells showed increased NEP mRNA and protein expression. Despite elevations in NEP protein, the activity was significantly lower compared with the NEP protein level. This study demonstrates that NEP can be inactivated by HNE-adduction, which is associated with, at least partly, reduced Aβ cleavage and enhanced Aβ accumulation.",
keywords = "β-amyloid, 4-hydroxy-nonenal, Alzheimer's disease, Degradation, Neprilysin, Oxidative stress",
author = "Rui Wang and Suqing Wang and Malter, {James S.} and Wang, {Deng Shun}",
year = "2009",
month = "2",
doi = "10.1111/j.1471-4159.2008.05855.x",
language = "English (US)",
volume = "108",
pages = "1072--1082",
journal = "Journal of Neurochemistry",
issn = "0022-3042",
publisher = "Wiley-Blackwell",
number = "4",

}

TY - JOUR

T1 - Effects of HNE-modification induced by Aβ on neprilysin expression and activity in SH-SY5Y cells

AU - Wang, Rui

AU - Wang, Suqing

AU - Malter, James S.

AU - Wang, Deng Shun

PY - 2009/2

Y1 - 2009/2

N2 - The cerebral accumulation of β-amyloid (Aβ) is a consistent feature of and likely contributor to the development of Alzheimer's disease. In addition to dysregulated production, increasing experimental evidence suggests reduced catabolism also plays an important role in Aβ accumulation. We have previously shown that neprilysin (NEP), the major protease which cleaves Aβin vivo, is modified by 4-hydroxy-nonenal (HNE) adducts in the brain of Alzheimer's disease patients. To determine if these changes affected Aβ, SH-SY5Y cells were treated with HNE or Aβ, and then NEP mRNA, protein levels, HNE adducted NEP, NEP activity and secreted Aβ levels were determined. Intracellular NEP developed HNE adducts after 24 h of HNE treatment as determined by immunoprecipitation, immunoblotting, and double immunofluorescence staining. HNE-modified NEP showed decreased catalytic activity, which was associated with elevations in Aβ1-40 in SH-SY5Y and H4 APP695wt cells. Incubation of cells with Aβ1-42 also induced HNE adduction of NEP. In an apparent compensatory response, Aβ-treated cells showed increased NEP mRNA and protein expression. Despite elevations in NEP protein, the activity was significantly lower compared with the NEP protein level. This study demonstrates that NEP can be inactivated by HNE-adduction, which is associated with, at least partly, reduced Aβ cleavage and enhanced Aβ accumulation.

AB - The cerebral accumulation of β-amyloid (Aβ) is a consistent feature of and likely contributor to the development of Alzheimer's disease. In addition to dysregulated production, increasing experimental evidence suggests reduced catabolism also plays an important role in Aβ accumulation. We have previously shown that neprilysin (NEP), the major protease which cleaves Aβin vivo, is modified by 4-hydroxy-nonenal (HNE) adducts in the brain of Alzheimer's disease patients. To determine if these changes affected Aβ, SH-SY5Y cells were treated with HNE or Aβ, and then NEP mRNA, protein levels, HNE adducted NEP, NEP activity and secreted Aβ levels were determined. Intracellular NEP developed HNE adducts after 24 h of HNE treatment as determined by immunoprecipitation, immunoblotting, and double immunofluorescence staining. HNE-modified NEP showed decreased catalytic activity, which was associated with elevations in Aβ1-40 in SH-SY5Y and H4 APP695wt cells. Incubation of cells with Aβ1-42 also induced HNE adduction of NEP. In an apparent compensatory response, Aβ-treated cells showed increased NEP mRNA and protein expression. Despite elevations in NEP protein, the activity was significantly lower compared with the NEP protein level. This study demonstrates that NEP can be inactivated by HNE-adduction, which is associated with, at least partly, reduced Aβ cleavage and enhanced Aβ accumulation.

KW - β-amyloid

KW - 4-hydroxy-nonenal

KW - Alzheimer's disease

KW - Degradation

KW - Neprilysin

KW - Oxidative stress

UR - http://www.scopus.com/inward/record.url?scp=58549086590&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549086590&partnerID=8YFLogxK

U2 - 10.1111/j.1471-4159.2008.05855.x

DO - 10.1111/j.1471-4159.2008.05855.x

M3 - Article

C2 - 19196432

AN - SCOPUS:58549086590

VL - 108

SP - 1072

EP - 1082

JO - Journal of Neurochemistry

JF - Journal of Neurochemistry

SN - 0022-3042

IS - 4

ER -